CLOSE X
GO

Kotak Healthcare Fund-Reg(G)

very highequitypharma & health care
13.05 0.12(0.90%) NAV as on 23 Apr 2025
0.52 % 1 M
17.64 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.39

As on 31 Mar, 2025
age-icon Age :

1 yrs 4 m

Since 11 12 ,2023
exit_load Exit Load :

0.5%

aum AUM :

411.54 Crs

lock_in Lock-in :

0.50% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.56

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Shibani Kurian,Abhishek Bisen,Dhananjay Tikariha

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others 1.73 %
Equity 98.27 %

TOP HOLDINGS

Sun Pharmaceutical Industries...17.91 %
Max Healthcare Institute Ltd.8.13 %
Cipla Ltd.6.03 %
Divi's Laboratories Ltd.5.05 %
Torrent Pharmaceuticals Ltd.3.84 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.18
Hospital & Healthcare Services21.89
Medical Equipment/Supplies/Accessories2.20
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)11.3312.75
Net Assets(Rs Crores) (as on 31-Mar-2025) 284.18 411.54
Scheme Returns(%)(Absolute)13.3211.67
B'mark Returns(%)(Absolute)NANA
Category Rank77/9027/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Kotak Healthcare Fund-Reg(G)Very HighEquity13.050.12(0.90%)NAV As on 23 Apr, 202511-Dec-2023Inception Date411.54AUM In Cr.17.64%1YNA%3YNA%5Y21.49%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.570.50(1.35%)NAV As on 23 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.24.40%1Y23.98%3Y25.65%5Y21.55%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.773.97(0.95%)NAV As on 23 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.24.04%1Y23.61%3Y25.30%5Y16.36%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.620.35(1.19%)NAV As on 23 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.20.10%1Y20.07%3Y22.33%5Y12.35%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors